Published in Headache on September 01, 1976
Migraine. CMAJ (1988) 0.81
New Prescriptions for Migraine in the Emergency Department: Treating a common affliction and presenting symptom. Can Fam Physician (1992) 0.75
Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia (1993) 1.41
Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia (2009) 1.18
A contribution to the interpretation of shock and pain in myocardial infarction. Mal Cardiovasc (1967) 1.13
An enzyme (MAO) defect on the platelets in migraine. Res Clin Stud Headache (1970) 1.04
Sex, migraine and serotonin interrelationships. Monogr Neural Sci (1976) 0.86
Systemic non-organic central pain: a new syndrome with decentralization supersensitivity. Headache (1978) 0.86
Multiple aspects of headache risk in children. Adv Neurol (1982) 0.85
Unmasking latent dysnociception in healthy subjects. Headache (1987) 0.84
Morphine abstinence and serotonin supersensitivity in man: analogies with the mechanism of migraine? Psychopharmacology (Berl) (1979) 0.80
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia (1973) 0.80
A statistical evaluation of the relationships between headache and internal frontal hyperostosis. Res Clin Stud Headache (1970) 0.79
Personality patterns of headache sufferers. Cephalalgia (1983) 0.79
Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man. Regul Pept (1987) 0.79
Change in serotonin and catecholamines vascular reactivity during migraine attack. Res Clin Stud Headache (1970) 0.79
Intermittent hypoendorphinaemia in migraine attack. Cephalalgia (1982) 0.77
Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial. J Int Med Res (1987) 0.77
Sexuality and headache. Adv Neurol (1982) 0.77
Guidelines and recommendations for the treatment of migraine in paediatric and adolescent patients. Italian Society for the Study of Headache. Funct Neurol (1997) 0.77
Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia (2001) 0.77
Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy? Adv Biochem Psychopharmacol (1980) 0.77
Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humans. Clin Pharmacol Ther (1988) 0.76
[5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine]. Clin Ter (1972) 0.76
Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline test. Monogr Neural Sci (1976) 0.76
Increased adverse effects of opiates in migraine patients. Cephalalgia (1995) 0.76
Impaired 5-hydroxytryptamine tachyphylaxis in migraine. Cephalalgia (1983) 0.76
Increased adverse effects of opiates in migraine patients. Cephalalgia (1994) 0.75
N-Methyl-benzylamine, a metabolite of pargyline in man. Br J Clin Pharmacol (1979) 0.75
Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis. Int J Clin Pharmacol Res (1984) 0.75
[Monoamine oxidase and essential arterial hypertension]. Boll Soc Ital Biol Sper (1967) 0.75
[Microvasoactive substances and vascular pain. Clinical experimental contribution]. Boll Soc Ital Biol Sper (1964) 0.75
[Monoamine oxidase inhibition and hypertensive paroxysms: importance of the method of administration]. Boll Soc Ital Biol Sper (1966) 0.75
[Vasoneuroactive substance, antiaminic BC-105 and migraine]. Clin Ter (1967) 0.75
Parachlorophenylalanine, an inhibitor of enteramine (serotonin) synthesis in migraine. Res Clin Stud Headache (1970) 0.75
The possible role of tryptophan in migraine. Adv Exp Med Biol (1996) 0.75
Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients. Headache (1994) 0.75
Endorphins in the pathogenesis of headache. Adv Neurol (1982) 0.75
[Clinico-pharmacological model of paroxysmal arterial hypertension]. Rass Neurol Veg (1969) 0.75
Painful vein overdistension in migraine patients: no relationship with serotoninergic parameters. Cephalalgia (1996) 0.75
[Do pyrogens have pain-producing properties?]. Boll Soc Ital Biol Sper (1966) 0.75
[Study of headache among growing children. Results and considerations in 126 cases]. Riv Neurobiol (1983) 0.75
The influence of tryptophan and parachlorophenylalanine on the sexual activity in man. Acta Vitaminol Enzymol (1975) 0.75
[Fenfluramine and headche: pharmaco-clinical implications]. Boll Soc Ital Biol Sper (1975) 0.75
Lisuride as a migraine prophylactic in children: an open clinical trial. Int J Clin Pharmacol Res (1983) 0.75
A therapeutic trial in migraine with parachlorophenylalanine, a specific serotonin depletor. Headache (1970) 0.75
Histamine and kallikrein system in man. Adv Exp Med Biol (1976) 0.75
Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus. Recenti Prog Med (1997) 0.75
5-Hydroxytryptamine and pain modulation in man: a clinical pharmacological approach with tryptophan and parachlorophenylalanine. Acta Vitaminol Enzymol (1975) 0.75
[Latency and evidence of pathology in migraine: clinico-pharmacological and therapeutic considerations on a drug antagonist of serotonin and histamine]. Clin Ter (1969) 0.75
[The antihistaminic Sandomigran as the treatment of choice in anxious, thin, and anorexic patients with migraine]. Schweiz Med Wochenschr (1972) 0.75
Clinical pharmacological aspects of dihydroergotamine timed release: activity on monoamine venospasm. Cephalalgia (1983) 0.75
Morphine-like factors in CSF of headache patients. Adv Biochem Psychopharmacol (1978) 0.75
[Dopaminergic disequilibria in hemicrania]. Acta Neurol (Napoli) (1985) 0.75
[Clinico-pathogenetic considerations on a case of periodic hypokalemic paralysis (with special reference to the possible role of the hypothalamus)]. Riv Crit Clin Med (1967) 0.75
Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache (1980) 0.75
[Adrenergic amines and monoaminoxidases in essential arterial hypertension]. Acta Vitaminol Enzymol (1969) 0.75
Clinical and animal pharmacology of migraine: new perspectives. Monogr Neural Sci (1976) 0.75
[Aphrodisiac action of MAO inhibitors and of parachlorophenylalanine (PCPA) in sexual asthenias]. Boll Soc Ital Biol Sper (1975) 0.75
Reduced serotonin vascular sensitivity in ergotamine abusers. Cephalalgia (1989) 0.75
[Bradykininase in the cerebrospinal fluid of humans]. Boll Soc Ital Biol Sper (1965) 0.75
Migraine-headache and essential arterial hypertension. A clinical pharmacological approach with the false transmitter metaraminol. Res Clin Stud Headache (1970) 0.75
[Bradykinin (kininogen-kinin system) in the pathogenesis of myocardial pain and shock]. Boll Soc Ital Cardiol (1966) 0.75
Naloxone reversal of 5-hydroxytryptamine tachyphylaxis in humans. Clin Neuropharmacol (1983) 0.75
Monoamine sensitivity of smooth muscle in vivo in nociception disorders. Adv Neurol (1982) 0.75
[Tryptaminuria and serotonin and catecholamine catabolism in the course of migraine]. Boll Soc Ital Biol Sper (1965) 0.75
[Liberation of plasmakinins by dilution of the blood in the cerebrospinal fluid]. Boll Soc Ital Biol Sper (1965) 0.75
Decentralization monoamine super-sensitivity of migraine and opiate abstinence: common features and different target mechanisms? Int J Clin Pharmacol Res (1997) 0.75
Kynin release by lysosomal labilization in man. Rass Neurol Veg (1969) 0.75
Sex differences in headache sufferers' responsiveness to painful overdistension of the hand-forearm veins. Funct Neurol (1995) 0.75
[Headache caused by analgesic and/or ergotamine abuse]. Clin Ter (1991) 0.75